ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201873 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201873; 2) Community: the network communities that were significantly associated with the response to NSC 201873; 3) Molecule: the relationships between components within communities and NSC 201873; 4) MDR: the compounds that were significantly associated with the NSC 201873.

NSC Compound Enrichment Correlation
NSC 228178 Palladate(1-), .mu.-chlorodichloro[.mu.-[2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazinecarboximidamidato]](2-)]di-, hydrogen 0.0177048892222172 0.066006607
NSC 3083 Null 0.0177048892222172 0.26981471
NSC 45828 Purine, 2,6,8-tris(hexylamino)- 0.0177048892222172 0.13562047
NSC 630734 Null 0.0177048892222172 0.1711069
NSC 645817 Null 0.0177048892222172 0.047191129
NSC 656204 Discorhabdin G 0.0177048892222172 0.3490307
NSC 677629 Furan-2-carboxamide, 3-(4-chlorophenyl)-N-cyclohexyl- 5-methoxy-4-(phenylsulfonyl)- 0.0177048892222172 0.079720682
NSC 678918 1,6-Phenazinedicarboxamide, N,N'-bis[2-(dimethylamino) ethyl]-, dihydrochloride 0.0177048892222172 0.29182894
NSC 693177 Ethyl 2-(5-methoxy-1-methyl-4,7-dioxoindol-3-yl)thiazole-4-carboxylate 0.0177048892222172 0.29103503
NSC 700552 4-Quinolinone, 6-bromo-1,2,3,4-tetrahydro-1-[(4-methylphenyl)sulfonyl]- 0.0177048892222172 0.50426825
Total:67  Current:23    [First] [Prev] [Next] [Last]